69 related articles for article (PubMed ID: 10876829)
1. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.
Donnelly LF; Bisset GS; Adams DM
Pediatr Radiol; 2000 Jun; 30(6):415-9. PubMed ID: 10876829
[TBL] [Abstract][Full Text] [Related]
2. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure.
Shin BS; Do YS; Lee BB; Kim DI; Chung IS; Cho HS; Kim MH; Kim GS; Kim CS; Byun HS; Shin SW; Park KB
Radiology; 2005 Jun; 235(3):1072-7. PubMed ID: 15833991
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous management of peripheral vascular malformations: a single center experience.
Türkbey B; Peynircioğlu B; Arat A; Canyiğit M; Ozer C; Vargel I; Balkanci F; Cil B
Diagn Interv Radiol; 2011 Dec; 17(4):363-7. PubMed ID: 21204044
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of sclerotherapy and embolization for arteriovenous and venous malformations.
Bowman J; Johnson J; McKusick M; Gloviczki P; Driscoll D
Semin Vasc Surg; 2013 Mar; 26(1):48-54. PubMed ID: 23932562
[TBL] [Abstract][Full Text] [Related]
5. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
Jain R; Bandhu S; Sawhney S; Mittal R
J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
[TBL] [Abstract][Full Text] [Related]
6. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation.
Lee KB; Kim DI; Oh SK; Do YS; Kim KH; Kim YW
J Vasc Surg; 2008 Nov; 48(5):1286-91. PubMed ID: 18829241
[TBL] [Abstract][Full Text] [Related]
7. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies.
Mason KP; Michna E; Zurakowski D; Koka BV; Burrows PE
Radiology; 2000 Oct; 217(1):127-32. PubMed ID: 11012433
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
10. [Interdisciplinary concept for classification and treatment of vascular anomalies in the head and neck].
Ernemann U; Hoffmann J; Breuninger H; Reinert S; Skalej M
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):402-9. PubMed ID: 12447652
[TBL] [Abstract][Full Text] [Related]
11. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit.
Chiramel GK; Keshava SN; Moses V; Mammen S; David S; Sen S
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):270-9. PubMed ID: 25148921
[TBL] [Abstract][Full Text] [Related]
13. A 6-year experience treating vascular malformations with foam sclerotherapy.
Markovic JN; Kim CY; Lidsky ME; Shortell CK
Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
[TBL] [Abstract][Full Text] [Related]
14. Ethanol sclerotherapy of peripheral venous malformations.
Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
[TBL] [Abstract][Full Text] [Related]
15. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
Lidsky ME; Markovic JN; Miller MJ; Shortell CK
J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
[TBL] [Abstract][Full Text] [Related]
18. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
Lee CH; Chen SG
Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
[TBL] [Abstract][Full Text] [Related]
19. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
[TBL] [Abstract][Full Text] [Related]
20. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]